Peter Holper

Tips and tricks from our application experts: AAV analysis with CE

Jan 24, 2025 | Biopharma, BioPhase 8800 system, Blogs, PA 800 system | 0 comments

Read time: 2 minutes

Peter Holper, Staff Applications Scientist at SCIEX, US, shares his tips and tricks on AAV analysis using CE with the BioPhase 8800 system and the PA 800 Plus system.

Tip 1: Leverage the flexibility in injection modes

When starting out with a new viral vector product, my recommendation is to compare three different modes of injection using UV detection. First, start with a standard electrokinetic injection, which allows for the highest theoretical resolution. Next, use a pressure/ hydrodynamic injection, which will inject the same plug regardless of sample ionic strength and provide a quick estimate of the titer. Finally, use a field-amplified sample stacking (FASS) injection to achieve the highest sensitivity, while understanding it is the most sensitive injection method to the ionic strength of the matrix. Comparing these three peak profiles can give significant insight into the optimal separation conditions for each molecule analyzed.

Tip 2: Deal with low sample amounts

During early-stage development of AAV vectors, oftentimes only a few micrograms of proteins or less are available for analytics. However, most analytical technology is not practical for applications with low protein concentration or small sample volumes. To improve the sensitivity of CE-SDS, my recommendation is to use laser-induced fluorescence (LIF) detection instead of UV absorbance. Comparing the results from the different injection types (tip 1) will help you determine if additional sensitivity and transition to LIF detection is needed.

Tip 3: Optimize fluorescence dye labelling

Labeling procedure can pose challenges and require optimization for each product. Currently, the most common fluorescent dye used in CE-SDS-LIF is Chromeo P503, which has a low quantum yield when not bound to a protein and thus does not require additional cleanup after conjugation. When optimizing the labeling procedure with Chromeo P503, I find the dye-to-protein ratio to be the most important factor. If this ratio is not optimal, low signal or high peak tailing is often observed. I find that estimating the protein titer by referring to the peak area achieved with pressure injection (tip 1) can be highly beneficial, since only the genome titer may be known at this point.

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

Peter Holper

Peter Holper has over 15 years of experience in biopharma, including his role as an analytical chemist at Eli Lilly and Company where he was responsible for developing the analytical control strategy for bioproducts. He has extensive experience in analytical method development for biologics and held various positions with increasing responsibility. Peter currently works at SCIEX as a Staff Applications Scientist in Redwood City, California, where he is responsible for developing and optimizing CE applications and providing customer demo sample analysis support.

0 Comments